This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Arcosa (ACA): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Arcosa (ACA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Arcosa, Inc. (ACA) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Arcosa (ACA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
All You Need to Know About Arcosa (ACA) Rating Upgrade to Buy
by Zacks Equity Research
Arcosa (ACA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Arcosa (ACA) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Arcosa (ACA) delivered earnings and revenue surprises of 28.07% and 3.26%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Aspen Aerogels (ASPN) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Aspen Aerogels (ASPN) delivered earnings and revenue surprises of 107.69% and 29.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Armstrong World Industries (AWI) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Armstrong World Industries (AWI) delivered earnings and revenue surprises of 14.05% and 2.66%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Arcosa (ACA) Buys Ameron, Expands Infrastructure Portfolio
by Zacks Equity Research
Arcosa (ACA) bolsters its infrastructure solutions through the Ameron acquisition.
Should You Invest in Arcosa (ACA) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Arcosa (ACA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Arcosa (ACA) to Boost Infrastructure Presence With Ameron Buyout
by Zacks Equity Research
Arcosa (ACA) inks a definitive agreement with NOV Inc to acquire Ameron, aiming to grow in infrastructure markets.
Zacks Industry Outlook Highlights Masco, TopBuild, Advanced Drainage Systems, Knife River and Arcosa
by Zacks Equity Research
Masco, TopBuild, Advanced Drainage Systems, Knife River and Arcosa are part of the Zacks Industry Outlook article.
5 Stocks to Buy From a Booming Building Products Industry
by Shrabana Mukherjee
A focus on operational efficiencies, higher government spending and improved residential market raise hopes for MAS, BLD, WMS, KNF and ACA.
Arcosa, Inc. (ACA) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Arcosa (ACA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
January CPI Comes in Hot But Underlying Inflation Pressures Remain Cool
by Mayur Thaker
i still expect core inflation to remain subdued which should keep a lid on yields, but cracks in consumer health and valuations remain top concerns
5 Low Leverage Stocks to Buy on Expectations of Rate Cuts
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy NSIT, ACA, CAH, PLAB and WING.
Installed Building (IBP) Up 67% in 3 Months: Will It Sustain?
by Zacks Equity Research
Solid demand, acquisitions and higher ROE look encouraging for Installed Building's (IBP) future.
Reasons to Retain Howmet (HWM) Stock in Your Portfolio Now
by Zacks Equity Research
Howmet (HWM) is set to gain from strength in the commercial aerospace and oil and gas markets within the Engine Products unit. Its measures to reward its shareholders are noteworthy.
SPX Rapidly Erasing YTD Gains As Earnings Guidance Disappoints
by Mayur Thaker
The leading indicators of earnings continue to point towards an earnings recession.
Arcosa (ACA) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Arcosa (ACA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Aspen Aerogels (ASPN) Soars 26.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Aspen Aerogels (ASPN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Are Investors Undervaluing Arcosa (ACA) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Construction Stocks Lagging Arcosa (ACA) This Year?
by Zacks Equity Research
Here is how Arcosa (ACA) and Boise Cascade (BCC) have performed compared to their sector so far this year.
Can Infrastructural Push Sustain Growth for Arcosa (ACA)?
by Zacks Equity Research
Strong infrastructure-related funding along with renewable push boost Arcosa's (ACA) prospects in the quarters ahead amid challenges.
Zacks.com featured highlights Addus HomeCare, Amalgamated Financial, ALLETE, Arcose and Limbach
by Zacks Equity Research
Addus HomeCare, Amalgamated Financial, ALLETE, Arcose and Limbach have been highlighted in this Screen of The Week article.
5 Low-Leverage Stocks to Buy as Market Woes Compound
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt. This is because a debt-free stock is almost impossible to find. You can buy ADUS, AMAL, ALE, ACA and LMB.
Should Value Investors Buy Arcosa (ACA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.